Reta stalled...now what?

[Xan2005]

The clen comparison at a stall is a common crossroads - people who've run stimulants before tend to look for something to add rather than adjusting what's already there. The albuterol preference over clen is pharmacologically defensible: beta-2 selectivity and shorter half-life reduce cardiac risk. Modafinil's controlled status makes sourcing friction a real variable. What's worth examining first at a Reta stall is whether the dose ladder has room - 4 months is often early for the ceiling, and the stall pattern at that mark frequently responds to a dose bump before any add-ons are needed. The glucagon comparison gets interesting because both affect hepatic glucose output, but the mechanisms differ enough that stacking logic requires knowing what the stall is from: metabolic adaptation, dose tolerance, or composition shift.

 

[Pin_Cookie]

Switching from split to weekly on the same dose is a real lever for stalls - the consolidated pulse affects the mechanism differently.

 

[Ozzy]

Sixty-day stalls on Reta are common after a fast early drop - the 25 lbs already happened, and the body adjusts to a new set point. Dose increase to 2mg is the standard next step, but strength training during that window changes body composition even when the scale stays flat.

 

[slim_pretzel6411]

The stall at 4mg when you look lean already is interesting - sometimes when you're close to what your body considers its natural set point, the scale stops moving even though composition keeps improving. If you look lean and feel good, it might be worth sitting at 4mg a bit longer before going higher.

 

[thyme_simmerer]

The 5% to 30% variation in trial outcomes is crucial framing for understanding plateaus - the average result is the average, not a guarantee for every individual. If Reta has given its initial benefit and plateaued, the case for trying something else or adding a layer is reasonable.